316 related articles for article (PubMed ID: 35289000)
1. As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic.
Muraleedharan M; Panda NK; Angrish P; Arora K; Patro SK; Bansal S; Chakrabarti A; Rudramurthy SM; Bakshi J; Mohindra S; Gupta R; Virk RS; Verma RK; Ramavat AS; Nayak G
Mycoses; 2022 May; 65(5):567-576. PubMed ID: 35289000
[TBL] [Abstract][Full Text] [Related]
2. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
3. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
4. Histomorphological features of mucormycosis with rise and fall of COVID-19 pandemic.
Ganesan N; Sivanandam S
Pathol Res Pract; 2022 Aug; 236():153981. PubMed ID: 35749915
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting clinical outcome in COVID-associated rhino-orbito-cerebral mucormycosis (CAROM) patients-An ambispective, single-arm, observational study.
Singh A; Goel G; Khan M; Kanodia A; Sikka K; Thakar A
Am J Otolaryngol; 2023; 44(6):103975. PubMed ID: 37478538
[TBL] [Abstract][Full Text] [Related]
6. Determinants of stroke in patients with rhino cerebral mucormycosis seen during the second wave of COVID-19 pandemic: A prospective cohort study.
Pandey S; Malhotra HS; Garg RK; Sharma K; Rizvi I; Kumar S; Kumar N; Uniyal R; Sharma PK; Gupta P; Jain A; Reddy DH
J Infect Public Health; 2022 Nov; 15(11):1265-1269. PubMed ID: 36272391
[TBL] [Abstract][Full Text] [Related]
7. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.
Raj A; Nishant P; Sadhukhan K; Saha BC; Sinha U; Kokkayil P; Gupta A; Kumar A; Tiwari P
Indian J Ophthalmol; 2023 Jan; 71(1):249-256. PubMed ID: 36588245
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.
Aggarwal SK; Kaur U; Talda D; Pandey A; Jaiswal S; Kanakan A; Singh A; Chakrabarti SS
Am J Trop Med Hyg; 2021 Dec; 106(2):566-570. PubMed ID: 34902834
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for severe rhino-orbital mucormycosis during its epidemic post-COVID-19 pandemic.
Das GK; Singh A; Beri N; Sahu PK; Bisht T; Sharma I
Indian J Public Health; 2022; 66(4):494-497. PubMed ID: 37039180
[TBL] [Abstract][Full Text] [Related]
12. Rise of the phoenix: Mucormycosis in COVID-19 times.
Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated mucormycosis in India: Why such an outbreak?
Pasquier G
J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
[TBL] [Abstract][Full Text] [Related]
14. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.
Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R
Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158
[TBL] [Abstract][Full Text] [Related]
15. The potential for rapid antigen testing for mucormycosis in the context of COVID-19.
Thornton CR
Expert Rev Mol Diagn; 2024 Mar; 24(3):161-167. PubMed ID: 37405409
[TBL] [Abstract][Full Text] [Related]
16. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
[TBL] [Abstract][Full Text] [Related]
17. Role of histopathology in severity assessments of post-COVID-19 rhino-orbital cerebral mucormycosis - A case-control study.
Shanmugasundaram S; Ramasamy V; Shiguru S
Ann Diagn Pathol; 2023 Dec; 67():152183. PubMed ID: 37696132
[TBL] [Abstract][Full Text] [Related]
18. Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.
Fatima N; Ahmed S; Shameem M; Ahmed A; Hasan W; Khan PA
Indian J Med Microbiol; 2023; 46():100467. PubMed ID: 37651764
[TBL] [Abstract][Full Text] [Related]
19. A retrospective clinicopathological analysis of rhino-orbital mucormycosis in second wave of COVID-19.
Thakur B; Ahuja S; Acharya S; Kaushik S
Indian J Pathol Microbiol; 2023; 66(2):411-414. PubMed ID: 37077099
[TBL] [Abstract][Full Text] [Related]
20. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
